Technical Feasibility for an Early Cannulation Vascular Access Graft with SLF(TM) Technology

血管流动技术公司打算在螺旋层流血管通道移植成功的基础上，为透析患者开发最好的治疗方法。**早期插管通道移植物的开发与专利的螺旋层流技术相结合，将允许移植后立即使用移植物**。通过开发内部端到端制造，Vascular Flow Technologies将牢固地建立自己作为领先的血管移植物制造商的地位，其设施位于英国。项目的第一阶段将解决技术可行性，探索制造方案的设计，并评估新的和现有的技术。项目的第二阶段最终将使维管流动技术公司建立全面的扩展聚四氟乙烯（ePTFE）接枝制造，利用现有资产并建立长期的供应链安全。

Vascular Flow Technologies intend to build on the success of the Spiral Laminar Flow Vascular Access Graft by developing the best treatment possible for dialysis patients. The development of an **Early Cannulation Access Graft coupled with the patented Spiral Laminar Flow technology will allow immediate use of the graft post implantation**. By developing in-house end-to-end manufacturing, Vascular Flow Technologies will firmly establish itself as a leading vascular graft manufacturer with facilities based in the UK. **Phase 1** of the project will address the technical feasibility and explore design for manufacture options and evaluate new and existing technologies. **Phase 2** of the project will ultimately lead to Vascular Flow Technologies setting up full scale expanded polytetraflurorethylene (ePTFE) graft manufacturing, capitalising on existing assets and creating long term supply chain security.